Co-Authors
This is a "connection" page, showing publications co-authored by ELSA ARRIBAS and BEATRIZ ELENA ADRADA.
Connection Strength
1.773
-
Multimodality Imaging of Benign and Malignant Diseases of the Nipple-Areolar Complex. Radiographics. 2024 Apr; 44(4):e230113.
Score: 0.249
-
Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. Radiographics. 2023 10; 43(10):e230034.
Score: 0.241
-
Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management. Insights Imaging. 2021 Apr 20; 12(1):53.
Score: 0.203
-
The role of three-dimensional printing in the surgical management of breast cancer. J Surg Oncol. 2019 Nov; 120(6):897-902.
Score: 0.181
-
Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015 Apr; 22(4):1111-7.
Score: 0.129
-
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014 Aug; 147(1):1-14.
Score: 0.127
-
Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features. AJR Am J Roentgenol. 2009 Jul; 193(1):W58-63.
Score: 0.090
-
Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm. AJR Am J Roentgenol. 2023 04; 220(4):512-523.
Score: 0.056
-
Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer. Ultrasound Med Biol. 2022 06; 48(6):1010-1018.
Score: 0.054
-
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection. Acad Radiol. 2022 07; 29(7):1039-1045.
Score: 0.052
-
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer. J Magn Reson Imaging. 2021 07; 54(1):251-260.
Score: 0.050
-
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat. 2021 Jan; 185(1):1-12.
Score: 0.049
-
Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. Eur J Radiol. 2020 Sep; 130:109170.
Score: 0.048
-
Imaging features of triple-negative breast cancers according to androgen receptor status. Eur J Radiol. 2019 May; 114:167-174.
Score: 0.044
-
Imaging of Intracystic Papillary Carcinoma. Curr Probl Diagn Radiol. 2019 Jul - Aug; 48(4):348-352.
Score: 0.041
-
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
Score: 0.041
-
Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol. 2018 Jul; 25(7):1953-1960.
Score: 0.041
-
Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. AJR Am J Roentgenol. 2011 Oct; 197(4):W761-8.
Score: 0.026
-
Investigating the limit of detectability of a positron emission mammography device: a phantom study. Med Phys. 2011 Sep; 38(9):5176-85.
Score: 0.026
-
Conspicuity of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. Acad Radiol. 2009 Dec; 16(12):1509-17.
Score: 0.023